Robert A. Lookstein, MD

Executive Vice Chair; Diagnostic, Molecular, and Interventional Radiology
Icahn School of Medicine at Mount Sinai

Presentation(s):

• Improvement in Right Ventricular Dysfunction by Echocardiography After Percutaneous Large-Bore Thromboaspiration for Patients with High- and Intermediate-High Risk Acute Pulmonary Embolism

  Sunday, March 5, 2023
  3:00 PM – 3:09 PM

  Disclosure(s): No relevant disclosure to display

• Pivotal, Prospective Multicenter US Study of Lava, a Liquid Embolic Agent Used to Treat Peripheral Arterial Hemorrhage

  Sunday, March 5, 2023
  3:36 PM – 3:45 PM

  Disclosure(s): No relevant disclosure to display

• Predicting Gastrointestinal Bleeding on CT Angiography: A Comparison of Logistic Regression and Machine Learning Models

  Sunday, March 5, 2023
  3:36 PM – 3:45 PM

  Disclosure(s): No relevant disclosure to display

• Initial Experience with an Artificial Intelligence System for Pulmonary Embolism Response Team Activation and Coordination in a Large Urban Health System

  Sunday, March 5, 2023
  3:45 PM – 3:54 PM

  Disclosure(s): No relevant disclosure to display

• Radioembolization plus Immune Checkpoint Inhibitor Therapy compared to Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma

  Sunday, March 5, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): No relevant disclosure to display

• Aorto-Iliac Disease

  Monday, March 6, 2023
  8:30 AM – 10:00 AM

  Disclosure(s): No relevant disclosure to display

• Radioembolization Prior to Checkpoint Inhibitor Immunotherapy versus Radioembolization Post Checkpoint Inhibitor Immunotherapy for the Treatment of Intermediate and Advanced Stage Hepatocellular Carcinoma

  Monday, March 6, 2023
  3:36 PM – 3:45 PM

  Disclosure(s): No relevant disclosure to display

• Y-90 vs. TACE Histopathologic Outcomes in Patients with HCC Who Underwent Orthotopic Liver Transplant: A Single-Center, 7-Year Experience

  Monday, March 6, 2023
  3:45 PM – 3:54 PM

  Disclosure(s): No relevant disclosure to display

• Effect Of Pharmacomechanical Catheter-Directed Thrombolysis On Pulmonary Segmental Artery Occlusions- Insights From The CTPA Core Laboratory Analysis Of The RESCUE Trial.

  Monday, March 6, 2023
  3:09 PM – 3:18 PM

  Disclosure(s): No relevant disclosure to display

• Geniculate Artery Embolization: Vascular Anatomy and Technical Considerations

  Monday, March 6, 2023
  5:40 PM – 5:45 PM

  Disclosure(s): No relevant disclosure to display

• IR’s Role in PE Management

  Tuesday, March 7, 2023
  1:00 PM – 2:30 PM

  Disclosure(s): No relevant disclosure to display

• Prospective, Multi-Center, Registry Study of Radial Access Embolization Procedures – 12 months outcomes (RAVI Registry - NCT04272216)

  Tuesday, March 7, 2023
  3:27 PM – 3:36 PM

  Disclosure(s): No relevant disclosure to display

• Percutaneous Cholecystocholangiography for Early Exclusion of Biliary Atresia: A Single Center 5-Year Experience

  Tuesday, March 7, 2023
  3:27 PM – 3:36 PM

  Disclosure(s): No relevant disclosure to display

• Best CLI trial

  Tuesday, March 7, 2023
  5:00 PM – 6:00 PM

  Disclosure(s): No relevant disclosure to display